The conference will take place June 27-29, and is jointly sponsored by the Susan G. Komen Breast Cancer Foundation and Howard University College of Medicine.

During the broadcast, host Selma R. Schimmel and a panel of experts will discuss the status of breast cancer research, education, screening and treatment projects supported by the Komen Foundation's Award and Research Grant Program and the Komen Affiliate Network.

The panelists include:

• Barrie R. Cassileth, PhD, Conference Chair; Laurance S. Rockefeller Chair in Integrative
  Medicine and Chief, Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center;
  
• Cheryl Perkins, MD, RPh, Senior Clinical Adviser, Susan G. Komen Breast Cancer Foundation;
  
• Gail Lebovic, MA, MD, Associate Director of the Henrietta C. Lee Breast Center,
  University of Southern California/Norris Comprehensive Cancer Center and Hospital;
  
• Venus Ginés, MA, Founder and CEO of Dia de la Mujer Latina, Inc., a health festival dedicate to providing Latina women with ethnic-specific information about breast health awareness and other health issues as well early detection screening;
  
• Selma Morris, MEd, Breast Health Liaison, Grady Health System, Atlanta.

"Collaborative broadcast opportunities with other cancer advocacy and related organizations allow us to bring diversity and important educational content to listeners. This is especially useful to those who cannot physically attend conferences, but want to participate and have a voice," said Schimmel, who is also the CEO and Founder of Vital Options International, as well as a breast and ovarian cancer survivor.

The Susan G. Komen Breast Cancer Foundation was established in 1982 by Nancy Brinker to honor the memory of her sister, Susan G. Komen, who died from breast cancer at the age of 36. Today, the Foundation is an international organization with a network of more than 75,000 volunteers working through local Affiliates and events like the Komen Race for the Cure® to eradicate breast cancer as a life-threatening disease. A global leader in the fight against breast cancer, the Foundation fulfills its mission through support of innovative breast cancer research grants, meritorious awards and educational, scientific and community outreach programs around the world.

Vital Options® is an international not-for-profit cancer communications, support and advocacy organization, headquartered in Southern California. It produces The Group Room in association with Premiere Radio Networks. The program airs live every Sunday in cities throughout the United States, reaching more than a half-million radio listeners a week, in addition to others who tune in via XM Satellite Radio Ask! Channel/XM165 or the Internet simulcast at www.vitaloptions.org where past shows are also archived. Callers enter on-air discussions toll-free by dialing 1-800-GRP-ROOM
(1-800-477-7666) or sending their comments and questions by email to info@vitaloptions.org.

The show features Schimmel and The Group Room's regular on-air medical experts--medical oncologist Dr. Michael Van Scoy-Mosher, radiation oncologist Dr. Leslie Botnick and therapist Halina Irving, MFCC--who are joined each week by callers affected by cancer, as well as renowned cancer experts and advocates who provide updates on research, medical advances and advocacy efforts. All phone calls are screened by a licensed oncology social worker. During the week, individuals can reach Vital Options for additional support services and information.

Founded in 1983, Vital Options was the first organization to address issues related to young adults with cancer before expanding to include patients of all ages and issues and information related to everyone touched by cancer. The Group Room regularly produces remote location broadcasts from the world's leading oncology meetings, such as the American Society of Clinical Oncology (ASCO) and its European equivalents, ECCO/ESMO, and from preeminent cancer centers in the United States and Europe.

Vital Options and The Group Room are supported through educational grants from corporate sponsors, Ortho Biotech Products, L.P., and Pfizer Oncology, and associate sponsor, Bristol-Myers Squibb Co. This broadcast has been made possible through additional support from the Susan G. Komen Breast Cancer Foundation.